SUNITINIB
sunitinib 37.5 mg capsule, 28
SUNITINIB (10503T)
10503T
Manner of administration:Oral
Restriction
Indication: Metastatic or unresectable malignant gastrointestinal stromal tumour
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 28 | # of repeats: 1 | DPMQ: $1,511.93 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||